Nanocrine, Inc.
PrivateLast Round
Seed
Jun 8, 2023
Total Funding Raised
$548,706
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Nanocrine, Inc. is a biotechnology company that develops nanoplasmonic biosensor platforms for the real-time imaging and quantification of protein secretions from living cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanocrine, Inc. Comparables
Compare Nanocrine, Inc. with similar companies based on industry and business-model similarity.
Nanocrine, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 8, 2023 | ||||
| Grant | Sep 1, 2020 |
Nanocrine, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TEDCO | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors increased 1708% MoM, reaching 1.2K.
- Sep 1, 2020
$249K grant awarded by the National Science Foundation.
Nanocrine, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nanocrine, Inc.'s valuation, stock price, and market status.